Two oral FTIs, lonafarnib and tipifarnib, are already in use as anti-tumor medication in humans and may become avenues of treatment for children suffering from laminopathic progeria.
Dous FTIs orais, lonafarnib e tipifarnib, xa se están a usar como medicación antitumoral en humanos e poden converterse nunha vía para tratar os nenos que padecen proxeria laminopática.